Substituted triazoloazine sulphonamides

US6297195A · kind A · utility

Assignee

• BAYER HEALTHCARE LLC · DE

Inventors

• Ernst Rudolf F. Gesing · Erkrath, DE
• Mark Wilhelm Drewes · Langenfeld, DE
• Johannes-Rudolf Jansen · Monheim, DE
• Rolf Kirsten · Monheim, DE
• Joachim Kluth · Langenfeld, DE
• Klaus-Helmut Muller · Düsseldorf, DE
• Ulrich Philipp · Neunburg vorm Wald, DE
• Hans-Jochem Riebel · Bad Camberg, DE
• Otto Schallner · Monheim, DE
• Detlef Wollweber · Wuppertal, DE
• Markus Dollinger · Leverkusen, DE
• Klaus Stenzel · Goldkronach, DE
• Christoph Erdelen · Leichlingen, DE

Key dates

• Filing date: May 10, 1999
• Grant date: Oct 2, 2001
• Expiry date: May 10, 2019

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A01N43/90
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The invention concerns novel substituted triazoloazine sulphonamides of formula (I) ##STR1## in which Q.sup.1 stands for nitrogen or a CH group: Q.sup.2 stands for nitrogen or a CH group; R.sup.1 stands for hydrogen or halogen, or for C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, C.sub.1 -C.sub.4 alkylthio, C.sub.1 -C.sub.4 alkylamino or di(C.sub.1 -C.sub.4 alkyl)amino, in each case optionally substituted by hydroxy, halogen or C.sub.1 -C.sub.4 alkoxy; R.sup.2 stands for hydrogen or halogen, or for C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, C.sub.1 -C.sub.4 alkylthio, C.sub.1 -C.sub.4 alkylamino or di(C.sub.1 -C.sub.4 alkyl)amino, in each case optionally substituted by halogen; and Ar stands for 4-cyano-2,5-difluoro-phenyl, 2,6-dimethoxy-phenyl, 2-bromo-3-trifluoro-methyl-phenyl, 2-bromo-5-trifluoromethyl-phenyl, 6-chloro-pyridine-3-yl-methyl or one of the 5- or 6-member (hetero)cyclic groups mentioned in the description. The invention also concerns salts of these substances, a process for preparing the novel compounds, and their use as plant-treatment agents.